In vivo dendritic cell reprogramming for cancer immunotherapy

Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to reprogram tumor cells in vivo by adenoviral deli...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Science
Autori principali: Ascic, Ervin, Åkerström, Fritiof, Nair, Malavika Sreekumar, Rosa, André, Kurochkin, Ilia, Zimmermannova, Olga, Catena, Xavier, Rotankova, Nadezhda, Veser, Charlotte, Rudnik, Michal, Ballocci, Tommaso, Schärer, Tiffany, Huang, Xiaoli, de Rosa Torres, Maria, Renaud, Emilie, Santiago, Marta Velasco, Met, Özcan, Askmyr, David, Lindstedt, Malin, Greiff, Lennart, Ligeon, Laure-Anne, Agarkova, Irina, Svane, Inge Marie, Pires, Cristiana F., Rosa, Fábio F., Pereira, Carlos-Filipe
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2024
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616765/
https://ncbi.nlm.nih.gov/pubmed/39236156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.adn9083
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi